|
1
|
Freeman AE and Hoffman RM: In vivo-like
growth of human tumors in vitro. Proc Natl Acad Sci USA.
83:2694–2698. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cole SP: Rapid chemosensitivity testing of
human lung tumor cells using the MTT assay. Cancer Chemother
Pharmacol. 17:259–263. 1986.PubMed/NCBI
|
|
3
|
Kobayashi H, Tanisaka K, Doi O, et al: An
in vitro chemosensitivity test for solid human tumors using
collagen gel droplet embedded cultures. Int J Oncol. 11:449–455.
1997.
|
|
4
|
Shaw GL, Gazdar AF, Phelps R, et al:
Individualized chemotherapy for patients with non-small cell lung
cancer determined by prospective identification of neuroendocrine
markers and in vitro drug sensitivity testing. Cancer Res.
53:5181–5187. 1993.PubMed/NCBI
|
|
5
|
Gazdar AF, Steinberg SM, Russell EK, et
al: Correlation of in vitro drug-sensitivity testing with response
to chemotherapy and survival in extensive-stage small cell lung
cancer: a prospective clinical trial. J Natl Cancer Inst.
82:117–124. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cortazar P, Gazdar AF, Woods E, et al:
Survival of patients with limited-stage small cell lung cancer
treated with individualized chemotherapy selected by in vitro drug
sensitivity testing. Clin Cancer Res. 3:741–747. 1997.PubMed/NCBI
|
|
7
|
Higashiyama M, Kodama K, Yokouchi H, et
al: Cisplatin-based chemotherapy for postoperative recurrence in
non-small cell lung cancer patients: Relation of the in
vitro chemosensitive test to clinical response. Oncol Rep.
8:279–283. 2001.PubMed/NCBI
|
|
8
|
Takamura Y, Kobayashi H, Taguchi T, et al:
Prediction of chemotherapeutic response by collagen gel droplet
embedded culture-drug sensitivity test in human breast cancers. Int
J Cancer. 98:450–455. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kikuchi T, Daigo Y, Katagiri T, et al:
Expression profiles of non-small cell lung cancers on cDNA
microarrays: identification of genes for prediction of lymph-node
metastasis and sensitivity to anti-cancer drugs. Oncogene.
22:2192–2205. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamaue H, Tanimura H, Noguchi K, et al:
Chemosensitivity testing of fresh human gastric cancer with highly
purified tumour cells using the MTT assay. Br J Cancer. 66:794–799.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takamura Y, Kobayashi H, Taguchi T,
Motomura K, Inaji H and Noguchi S: Prediction of chemotherapeutic
response by collagen gel droplet embedded culture-drug sensitivity
test in human breast cancers. Int J Cancer. 98:450–455. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakahara T, Sakaeda T, Nakamura T, et al:
Chemosensitivity assessed by collagen gel droplet embedded culture
drug sensitivity test, and MDR1, MRP1 and MRP2 mRNA expression in
human colorectal adenocarcinomas. Pharm Res. 21:406–412. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagai N, Minamikawa K, Mukai K, Hirata E,
Komatsu M and Kobayashi H: Predicting the chemosensitivity of
ovarian and uterine cancers with the collagen gel droplet culture
drug-sensitivity test. Anticancer Drugs. 16:525–531. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shimizu T, Murata S, Mekata E, et al:
Clinical potential of an antitumor drug sensitivity test and
diffusion-weighted MRI in a patient with a recurrent solid
pseudopapillary tumor of the pancreas. J Gastroenterol. 42:918–922.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cartazar P and Johnson BE: Review of the
efficacy of individualized chemotherapy selected by in vitro drug
sensitivity testing for patients with cancer. J Clin Oncol.
17:1625–1631. 1999.PubMed/NCBI
|
|
16
|
Bunn PA and Kelly K: New chemotherapeutic
agents prolong survival and improve quality of life in non-small
cell lung cancer: a review of the literature and future directions.
Clin Cancer Res. 5:1087–1100. 1998.PubMed/NCBI
|
|
17
|
Schiller JH, Harrington D, Belani CP, et
al; Eastern Cooperative Oncology Group. Comparison of four
chemotherapy regimens for advanced non-small cell lung cancer. N
Engl J Med. 346:92–98. 2002. View Article : Google Scholar
|
|
18
|
Goya T, Asamura H, Yoshimura H, et al: The
Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644
resected non-small cell lung cancers in Japan: a Japanese Lung
Cancer Registry Study. Lung Cancer. 50:227–234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
The International Adjuvant Lung Cancer
Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in
patients with completely resected non-small cell lung cancer. N
Engl J Med. 350:350–360. 2004.PubMed/NCBI
|
|
20
|
Kato H, Ichinose Y, Ohta M, et al: A
randomized trial of adjuvant chemotherapy with uracil-tegafur for
adenocarcinoma of the lung. N Engl J Med. 350:1713–1721. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tada H, Tsuchiya R, Ichinose Y, et al: A
randomized trial comparing adjuvant chemotherapy versus surgery
alone for completely resected pN2 non-small cell lung cancer. Lung
Cancer. 43:167–173. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Keller SM, Adak S, Wagner H, et al: A
randomized trial of postoperative adjuvant therapy in patients with
completely resected stage II or IIIA non-small cell lung cancer. N
Eng J Med. 343:1217–1222. 2000. View Article : Google Scholar : PubMed/NCBI
|
